These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3313526)

  • 1. Effect of platelet-activating factor (PAF-acether) and its specific receptor antagonist, BN 52021, on interleukin 1 (IL1) release and synthesis by rat spleen adherent monocytes.
    Pignol B; Hénane S; Mencia-Huerta JM; Rola-Pleszczynski M; Braquet P
    Prostaglandins; 1987 Jun; 33(6):931-9. PubMed ID: 3313526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N; Etienne A; Braquet P
    Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
    Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
    Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of platelet-activating factor on electrophysiology of isolated retinas and their inhibition by BN 52021, a specific PAF-acether receptor antagonist.
    Doly M; Bonhomme B; Braquet P; Chabrier PE; Meyniel G
    Immunopharmacology; 1987 Jun; 13(3):189-94. PubMed ID: 3038784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.
    Desquand S; Touvay C; Randon J; Lagente V; Vilain B; Maridonneau-Parini I; Etienne A; Lefort J; Braquet P; Vargaftig BB
    Eur J Pharmacol; 1986 Aug; 127(1-2):83-95. PubMed ID: 3019727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization and antagonism of rat polymorphonuclear leukocytes stimulated with PAF acether.
    Bureau M; Joseph D; Vargaftig BB
    Prostaglandins; 1987 Jan; 33(1):37-50. PubMed ID: 3035615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021.
    Baranes J; Hellegouarch A; Le Hegarat M; Viossat I; Auguet M; Chabrier PE; Braquet P
    Pharmacol Res Commun; 1986 Aug; 18(8):717-37. PubMed ID: 3763677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether.
    Sánchez-Crespo M; Fernández-Gallardo S; Nieto ML; Baranès J; Braquet P
    Immunopharmacology; 1985 Oct; 10(2):69-75. PubMed ID: 3840779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets.
    Simon MF; Chap H; Braquet P; Douste-Blazy L
    Thromb Res; 1987 Feb; 45(4):299-309. PubMed ID: 3576518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021.
    Etienne A; Hecquet F; Soulard C; Spinnewyn B; Clostre F; Braquet P
    Agents Actions; 1986 Jan; 17(3-4):368-70. PubMed ID: 3515870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
    Etienne A; Hecquet F; Guilmard C; Soulard C; Braquet P
    Int J Tissue React; 1987; 9(1):19-26. PubMed ID: 3596954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
    Lachachi H; Plantavid M; Simon MF; Chap H; Braquet P; Douste-Blazy L
    Biochem Biophys Res Commun; 1985 Oct; 132(2):460-6. PubMed ID: 2998370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021.
    Rola-Pleszczynski M; Pignol B; Pouliot C; Braquet P
    Biochem Biophys Res Commun; 1987 Feb; 142(3):754-60. PubMed ID: 3493773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of paf-acether in the mediation of pathophysiological responses to aggregated immunoglobulins. Studies with the platelet-activating factor receptor antagonist BN 52021.
    Fernandez-Gallardo S; Cano E; Braquet P; Sanchez Crespo M
    Int J Immunopharmacol; 1988; 10(4):353-60. PubMed ID: 3139574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of a role for PAF-acether in the pathophysiology of the shock state.
    Sanchez Crespo M; Inarrea P; Nieto ML; Fernandez-Gallardo S
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():181-96. PubMed ID: 3774844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of platelet-activating factor on hypothalamic and hypophyseal pro-opiomelanocortin-related peptides and hypothalamo-pituitary-adrenal axis in the rat.
    Blasquez C; Jégou S; Delarue C; Delbende C; Bunel DT; Braquet P; Vaudry H
    Eur J Pharmacol; 1990 Feb; 177(3):145-53. PubMed ID: 2155805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba.
    Lamant V; Mauco G; Braquet P; Chap H; Douste-Blazy L
    Biochem Pharmacol; 1987 Sep; 36(17):2749-52. PubMed ID: 2820421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba.
    Touvay C; Etienne A; Braquet P
    Agents Actions; 1986 Jan; 17(3-4):371-2. PubMed ID: 3754380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
    López-Farré A; Bernabeu F; Gómez-Garre D; Ramon y Cajal S; Braquet P; López-Novoa JM
    J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term treatment with platelet-activating factor on IL-1 and IL-2 production by rat spleen cells.
    Pignol B; Hénane S; Sorlin B; Rola-Pleszczynski M; Mencia-Huerta JM; Braquet P
    J Immunol; 1990 Aug; 145(3):980-4. PubMed ID: 2373865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.